Evidence map›Paper›PMID 30814666›Full record

ArticleScientific reports2019

Ample glycosylation in membrane and cell envelope proteins may explain the phenotypic diversity and virulence in the Mycobacterium tuberculosis complex.

Alemayehu Godana Birhanu, Solomon Abebe Yimer, Shewit Kalayou, Tahira Riaz, Ephrem Debebe Zegeye, Carol Holm-Hansen, Gunnstein Norheim, Abraham Aseffa, Markos Abebe, Tone Tønjum

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 48 citations in OpenAlex.

  1. Recent Characterization of Key Proteins to Combat Tuberculosis.Advances in experimental medicine and biology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Exposure ofFrontiers in tuberculosis · 2024
    Article
  6. Article
  7. Frontiers in immunology · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Evolution of Drug-ResistantFrontiers in microbiology · 2021
    Review
  17. Genetic Diversity inAnnual review of genetics · 2020
    Review
  18. Article
  19. Article
  20. Rv2577 ofFrontiers in microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Alemayehu Godana BirhanuDepartment of Microbiology, University of Oslo, PO Box 4950, Nydalen, NO-0424, Oslo, Norway. alexbiology97@yahoo.com.
Solomon Abebe YimerDepartment of Microbiology, University of Oslo, PO Box 4950, Nydalen, NO-0424, Oslo, Norway.
Shewit KalayouInternational Center of Insect Physiology and Ecology (ICIPE), P.O. Box 30772-00100, Nairobi, Kenya.
Tahira RiazDepartment of Microbiology, University of Oslo, PO Box 4950, Nydalen, NO-0424, Oslo, Norway.
Ephrem Debebe ZegeyeCentre for Applied Biotechnology, Uni Research Environment, Bergen, Norway.
Carol Holm-HansenInfection Control and Environmental Health, Norwegian Institute of Public Health, PO Box 4404, Nydalen, NO-0403, Oslo, Norway.
Gunnstein NorheimCoalition for Epidemic Preparedness Innovations (CEPI), P.O. BOX 123, Torshov, 0412, Oslo, Norway.
Abraham AseffaArmauer Hansen Research Institute, Jimma Road, PO Box 1005, Addis Ababa, Ethiopia.
Markos AbebeArmauer Hansen Research Institute, Jimma Road, PO Box 1005, Addis Ababa, Ethiopia.
Tone TønjumDepartment of Microbiology, University of Oslo, PO Box 4950, Nydalen, NO-0424, Oslo, Norway. tone.tonjum@medisin.uio.no.ORCID 0000-0002-1709-6921
University of Oslo · NOArmauer Hansen Research Institute · ETInternational Centre of Insect Physiology and Ecology · KENorwegian Institute of Public Health · NOUni Research (Norway) · NO

Funding

Ethiopia-Emory TB Research Training ProgramD43TW009127 · FIC · EMORY UNIVERSITY · PI HENRY M BLUMBERG, Kidist Bobosha · 2013 to 2026
$3.4M
FIC NIH HHS D43 TW009127
6 · The paper itself

Abstract

Multiple regulatory mechanisms including post-translational modifications (PTMs) confer complexity to the simpler genomes and proteomes of Mycobacterium tuberculosis (Mtb). PTMs such as glycosylation play a significant role in Mtb adaptive processes. The glycoproteomic patterns of clinical isolates of the Mycobacterium tuberculosis complex (MTBC) representing the lineages 3, 4, 5 and 7 were characterized by mass spectrometry. A total of 2944 glycosylation events were discovered in 1325 proteins. This data set represents the highest number of glycosylated proteins identified in Mtb to date. O-glycosylation constituted 83% of the events identified, while 17% of the sites were N-glycosylated. This is the first report on N-linked protein glycosylation in Mtb and in Gram-positive bacteria. Collectively, the bulk of Mtb glycoproteins are involved in cell envelope biosynthesis, fatty acid and lipid metabolism, two-component systems, and pathogen-host interaction that are either surface exposed or located in the cell wall. Quantitative glycoproteomic analysis revealed that 101 sites on 67 proteins involved in Mtb fitness and survival were differentially glycosylated between the four lineages, among which 64% were cell envelope and membrane proteins. The differential glycosylation pattern may contribute to phenotypic variabilities across Mtb lineages. The study identified several clinically important membrane-associated glycolipoproteins that are relevant for diagnostics as well as for drug and vaccine discovery.

Indexed as

Cell MembraneCell WallDrug Resistance, Multiple, BacterialExtensively Drug-Resistant TuberculosisGlycoproteinsGlycosylationHost-Pathogen InteractionsHumansMembrane ProteinsMycobacterium tuberculosisProtein Processing, Post-TranslationalTuberculosis, PulmonaryVirulenceGlycoproteinsMembrane Proteins

Identifiers

PMID30814666
PMCPMC6393673
OpenAlexW2916765270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.